Wells Fargo Maintains Overweight on Tenet Healthcare, Raises Price Target to $231
تينيت للرعاية الصحية
Tenet Healthcare Corporation THC | 0.00 |
Wells Fargo analyst Stephen Baxter maintains Tenet Healthcare (NYSE:
THC) with a Overweight and raises the price target from $213 to $231.
